Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Middle East and Africa Infusion Bags market was valued at USD 27.09 Million in 2025 and is expected to grow at a CAGR of 4.20%, reaching USD 40.88 Million by 2035. The market growth is driven by the rising prevalence of chronic diseases, increasing surgical procedures and hospital admissions, expanding demand for intravenous therapies, growing adoption of home-based infusion care, supportive healthcare infrastructure investments, and the transition toward safer non-PVC and DEHP-free infusion bags across the region.
Compound Annual Growth Rate
4.2%
Value in USD Million
2026-2035
Read more about this report - Request a Free Sample
The Middle East and Africa Infusion Bags Market comprises a broad range of sterile medical containers used for the intravenous administration of fluids, electrolytes, parenteral nutrition, blood and blood components, dialysis solutions, and injectable medications. The market includes intravenous (IV) solution bags, total parenteral nutrition (TPN) bags, blood bags, dialysis solution bags, specialty infusion bags, and associated fluid delivery systems manufactured using PVC and non-PVC materials. Infusion bags play a vital role in fluid management, drug delivery, nutritional support, and transfusion therapy across hospitals, ambulatory surgical centers, specialty clinics, and home healthcare settings. The market was valued at USD 27.09 Million in 2025, driven by the rising prevalence of chronic diseases requiring intravenous therapy, increasing surgical procedures and hospital admissions, growing demand for home-based infusion care, expanding adoption of DEHP-free and non-PVC infusion bags, supportive healthcare investments across Middle East and Africa, and continuous advancements in sterile manufacturing technologies, material innovation, and infusion safety systems.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Rising chronic disease burden, expanding oncology and dialysis services, increasing surgical procedures, and healthcare infrastructure development. | In 2025, B. Braun expanded infusion therapy production capacity and connected infusion technologies, strengthening global intravenous care capabilities. |
|
Market Restraints |
Raw material price volatility, stringent regulatory requirements, inflationary pressures, currency fluctuations, and rising manufacturing costs. | In 2025, Saudi Arabia advanced medical device localization under Vision 2030 to strengthen supply chains amid rising production costs. |
|
Market Opportunities |
Adoption of sustainable non-PVC infusion technologies, expanding home infusion services, and increasing healthcare localization initiatives. | In 2025, B. Braun promoted DEHP- and PVC-free infusion containers, improving patient safety, drug compatibility, and environmental sustainability. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Rising Chronic Disease Burden and Expanding Intravenous Care Accelerate Infusion Bag Demand
The rising burden of chronic diseases, expanding oncology and dialysis services, and increasing surgical volumes are accelerating demand for infusion bags across the Middle East and Africa. As per Miguel Ángel Rodríguez-Calero et al., 2025, safe vascular access and optimized intravenous therapy are fundamental to improving clinical outcomes and healthcare efficiency. During 2025, B. Braun strengthened its global infusion therapy portfolio through continued investment in production capacity and connected infusion technologies. Simultaneously, healthcare infrastructure expansion and localization initiatives across Gulf countries are attracting long-term capital, reinforcing procurement resilience despite inflationary and currency-related pressures.
Raw Material Price Volatility and Evolving Regulatory Standards Increase Manufacturing Costs
The Middle East and Africa infusion bags market continues to face challenges from fluctuating prices of medical-grade polymers, multilayer films, and packaging materials alongside increasingly stringent regulatory compliance requirements. According to the World Health Organization (WHO), 2025, strengthening regulatory systems and ensuring access to quality-assured medical products remain regional priorities. During 2025, Saudi Arabia advanced medical device localization and pharmaceutical manufacturing under Vision 2030 to enhance supply-chain resilience. Nevertheless, inflationary pressures, elevated financing costs, and currency volatility across several African economies continue increasing production expenses, encouraging manufacturers to invest in localized production and operational efficiencies that support long-term market growth.
Sustainable Non-PVC Technologies and Home Infusion Create Long-Term Growth Opportunities
Sustainable non-PVC infusion technologies and expanding home-based infusion services are creating significant long-term growth opportunities across the Middle East and Africa. According to B. Braun, 2025, DEHP- and PVC-free infusion containers enhance patient safety, drug compatibility, and environmental sustainability. During 2025, Saudi Arabia accelerated healthcare localization and pharmaceutical manufacturing under Vision 2030, strengthening regional medical supply resilience. Simultaneously, expanding home healthcare services are increasing demand for advanced infusion systems. Rising public investment, economic diversification, and industrial localization continue attracting healthcare capital despite inflationary and financing pressures, reinforcing long-term market expansion.
Rapid Transition Toward Non-PVC and DEHP-Free Infusion Bags Emerges as the Defining Market Trend
The transition toward non-PVC and DEHP-free infusion bags is emerging as the defining trend in the Middle East and Africa infusion bags market, driven by increasing emphasis on patient safety, pharmaceutical compatibility, and sustainable healthcare procurement. According to B. Braun, 2025, healthcare systems are increasingly adopting IV containers manufactured without PVC or DEHP to reduce chemical exposure and improve environmental performance. During 2025, Gulf countries continued advancing healthcare localization and sustainable procurement under national transformation strategies, encouraging adoption of advanced infusion technologies. Rising public healthcare investment, economic diversification, and regional manufacturing initiatives continue attracting long-term capital despite persistent inflationary and supply-chain pressures, supporting sustained market expansion.
Intravenous Fluid Therapy is Likely to Dominate the Market Share by Application
Intravenous fluid therapy is expected to dominate the Middle East and Africa infusion bags market owing to its indispensable role in perioperative care, trauma, sepsis, oncology, renal disease, and critical care. According to the World Health Organization Eastern Mediterranean Regional Office (WHO EMRO), 2025, strengthening access to essential medical products and resilient regional supply chains remains a strategic healthcare priority. During 2025, Saudi Arabia accelerated domestic intravenous fluid manufacturing under Vision 2030, reinforcing supply security. Rising healthcare investment, localization policies, and expanding hospital infrastructure continue to attract capital, supporting sustained demand for infusion bags despite persistent global inflation and logistics volatility.
Read more about this report - Request a Free Sample
Saudi Arabia is expected to dominate the Middle East and Africa infusion bags market owing to its expanding healthcare infrastructure, increasing hospital capacity, rising burden of chronic diseases, and growing demand for intravenous therapies across tertiary care, emergency medicine, and critical care settings. According to the Saudi Food and Drug Authority (SFDA), 2025, continued regulatory initiatives to strengthen the availability and quality of medical devices, including infusion products, are supporting healthcare system modernization. During 2025, ongoing investments under Saudi Vision 2030, alongside capacity expansion across public and private hospitals and increasing procurement of advanced medical consumables, have reinforced demand for infusion bags. Supported by sustained healthcare expenditure, increasing localization of medical manufacturing, and continued investment in healthcare infrastructure despite global macroeconomic uncertainties, Saudi Arabia remains the principal growth engine for the Middle East and Africa infusion bags market.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
B. Braun SE remains one of Middle East and Africa's leading infusion therapy companies, reporting continued revenue growth driven by its Hospital Care and Avitum divisions. Its infusion portfolio includes PVC-free IV solution bags, parenteral nutrition containers, elastomeric infusion systems, and automated infusion technologies. Operating in more than 60 countries with products available in over 190 markets, the company maintains a strong global healthcare footprint. During 2024–2025, B. Braun expanded investments in pharmaceutical manufacturing capacity and digital infusion solutions to strengthen supply resilience. The company operates under ISO 13485-certified quality systems, with products carrying CE Marking, MDR compliance, and other international regulatory certifications.
Becton, Dickinson and Company reported solid financial performance during 2024–2025, supported by its medical segment and Medication Management Solutions business. The company's infusion portfolio includes IV bags, prefillable systems, infusion sets, vascular access devices, and smart medication delivery technologies. BD serves healthcare providers in more than 190 countries through a broad manufacturing and distribution network. In 2025, the company continued expanding connected medication management platforms and infusion safety technologies while investing in manufacturing efficiency. BD maintains ISO 13485-certified facilities, CE Marked products, U.S. FDA compliance, and extensive global regulatory approvals
Fresenius Kabi AG continued strengthening its financial position in 2024–2025 through growth in clinical nutrition, infusion therapy, and biopharmaceutical businesses. The company offers a comprehensive portfolio including IV solution bags, parenteral nutrition bags, drug admixture systems, infusion pumps, and oncology preparations. Operating across more than 100 countries, Fresenius Kabi serves hospitals, pharmacies, and outpatient providers worldwide. Recent investments focused on sterile pharmaceutical manufacturing expansion and enhanced Middle East and African production capabilities to improve supply security. The company complies with ISO 13485, EU Medical Device Regulation (MDR), CE Marking requirements, and Good Manufacturing Practice (GMP) standards.
ICU Medical continued integrating its infusion therapy portfolio following previous acquisitions, supporting steady business performance throughout 2024–2025. Its offerings include IV solution containers, infusion pumps, IV administration sets, needle-free connectors, and oncology infusion systems. The company supplies healthcare providers in more than 100 countries, emphasizing medication safety and infusion workflow optimization. During 2024–2025, ICU Medical expanded manufacturing capacity and introduced enhancements to its Plum and LifeShield infusion platforms. Its manufacturing facilities comply with ISO 13485, FDA Quality System Regulation (QSR), CE Marking, and multiple international quality standards.
Other key players in the market include Nipro Corporation, McKesson Corporation, Terumo Corporation, Baxter International Inc., PolyCine GmbH and KIEFEL GmbH.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
The Middle East and Africa infusion bags market is segmented by product type based on the intended clinical use of infusion containers across healthcare settings. Product innovation, increasing hospital admissions, expanding chronic disease management, and rising demand for sterile fluid administration continue to support adoption across diverse therapeutic applications.
Market Breakup by Material
The market is segmented by material according to the polymer composition used in manufacturing infusion bags. Material selection is influenced by drug compatibility, patient safety, environmental regulations, flexibility, sterilization performance, and the growing transition toward safer, DEHP-free, and non-PVC alternatives across Middle East and African healthcare systems.
Market Breakup by Capacity
The market is segmented by capacity based on the volume of fluid delivered for different therapeutic requirements. Capacity selection varies according to treatment protocols, patient population, infusion duration, and clinical applications ranging from small-dose medications to large-volume hydration and nutritional support.
Market Breakup by Application
The market is segmented by application according to the clinical purpose for which infusion bags are utilized. Increasing demand for intravenous therapies, critical care services, nutritional support, renal disease treatment, and blood transfusion procedures continues to expand the use of infusion bags across multiple therapeutic disciplines.
Market Breakup by End User
The market is segmented by end users based on the healthcare facilities utilizing infusion bags for patient treatment. Demand is supported by expanding hospital infrastructure, rising outpatient procedures, increasing home-based care, and the growing need for efficient intravenous therapy across diverse clinical environments.
Market Breakup by Distribution Channel
The market is segmented by distribution channel according to the primary pathways through which infusion bags are supplied to healthcare providers and patients. Distribution efficiency, procurement practices, digital pharmacy expansion, and healthcare accessibility influence purchasing patterns across the Middle East and African market.
Market Breakup by Region
The Middle East and Africa infusion bags market is segmented by region based on differences in healthcare infrastructure, regulatory frameworks, demographic trends, healthcare expenditure, and adoption of advanced infusion technologies. Regional variation reflects disparities in chronic disease burden, hospital capacity, and medical device procurement across Middle East and Africa.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Material |
|
| Breakup by Capacity |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.